This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schilling, R. J. Articles by Davies, D. W. Search for Related Content PubMed PubMed Citation Articles by Schilling, R. J. Articles by Davies, D. W. Related Collections Electrophysiology Catheter-based coronary interventions: stents Arrhythmias, clinical electrophysiology, drugs

(Circulation. 1999;99:2543-2552.)
© 1999 American Heart Association, Inc.

Clinical Investigation and Reports

Feasibility of a Noncontact Catheter for Endocardial Mapping of Human Ventricular Tachycardia

Richard J. Schilling, MB; Nicholas S. Peters, MD; D. Wyn Davies, MD

From St Mary's Hospital and Imperial College School of Medicine, London, UK.

Correspondence to D. Wyn Davies, Waller Department of Cardiology, St Mary's Hospital, Praed St, London W2 1NY, UK.

	Abstract

Top Abstract Introduction Methods Results Discussion References

 
Background—Catheter ablation of ventricular tachycardia (VT) is limited by difficulty in identifying suitable sites for ablation. This study assesses use of a system capable of simultaneous endocardial mapping of the human left ventricle to map and guide radiofrequency (RF) catheter ablation of VT.

Methods and Results—A catheter-mounted noncontact multielectrode array was used to reconstruct 3360 electrograms, superimposed onto a computer-simulated endocardial model. Of 24 patients studied, 20 had ischemic heart disease. Exit sites were demonstrated by the noncontact system in 80 (99%) of 81 VTs, with complete VT circuits traced in 17 (21%). In another 37 VTs, 36±30% (mean±SD) of the diastolic interval was identified. Thirty-eight VT morphologies were ablated with 154 RF energy applications. Successful ablation was achieved by 77% of RF applications to relevant diastolic activity identified by the system and was significantly more likely (P<0.0001) than by RF at the VT exit or remote from diastolic activation. Over a mean follow-up of 1.5 years, 14 patients (64%) have had no recurrence of VT, and only 2 target VTs (5.3%) have recurred. Five patients have had recurrence of other VTs.

Conclusions—This noncontact mapping system identified diastolic portions of the circuit in most VTs studied and can safely map and guide ablation of human VT.

Key Words: ablation • ventricles • tachycardia

	Introduction

Top Abstract Introduction Methods Results Discussion References

 
Inducible ventricular tachycardias (VTs) are poorly suppressed by medication,¹ such failure carrying a poor prognosis.² Empirical drug therapy risks proarrhythmic effects.³ Palliation with implantable cardioverter-defibrillators (ICDs) is increasing⁴ but is not ideal for patients being treated for frequent or slow VT.

Catheter ablation may eliminate VT with less risk than surgical ablation.⁵ For reentrant VT,^{6 7} ablation targets the diastolic activity that maintains reentry.^{7 8} Of patients with structural heart disease and VT, 10% have been considered suitable for catheter ablation,⁹ because hemodynamic intolerance of VT prevents conventional mapping. A percutaneous mapping system producing high-resolution endocardial activation maps of the entire left ventricle (LV)¹⁰ has been validated in humans during sinus rhythm.¹¹ We report its first use in catheter ablation of human VT.

	Methods

Top Abstract Introduction Methods Results Discussion References

 
Patients
Twenty-four patients were studied during endocardial LV mapping for ablation of VT (Table 1). Twenty-one were on amiodarone, and 4 were also on another antiarrhythmic agent. Eight patients with ICDs had unacceptably frequent or slow VT. The remaining patients had well-tolerated VT refractory to medical therapy. Two patients had normal LVs, 1 with fascicular and 1 with LV outflow tract tachycardia.

View this table: [in this window] [in a new window]   Table 1. Patient Characteristics

Mapping Procedure
The study was approved by the local ethics committee, whose guidelines were followed. A quadripolar catheter was placed in the right ventricle, and two 7F 4-mm-tip catheters were passed to the LV via the aorta and transseptally. Contact catheter data and ECGs were recorded simultaneously on another EP system. This and the procedure have been described previously.¹¹

Mapping Protocol
Validation of Reconstructed Electrograms
VT electrograms selected from sites of interest were displayed and compared with contact unipolar electrograms from the same site, as identified by the locator. Off-line analysis used cross-correlation techniques.^{11 12}

Isopotential Mapping
Voltages are displayed as a colored isopotential map on the virtual endocardium. The color scale is adjusted to create a binary display, with negative unipolar potentials in white on a purple background, producing a unipolar activation map. Diastolic depolarization was strictly defined as activity on the isopotential map (Figure 1) that could be continuously tracked back in time from VT exit sites, defined on the map as synchronous with the QRS onset (Figures 1 and 2). Diastolic activity and exit sites were then marked on the virtual endocardium, and a mapping catheter was navigated to them by the locator. If these sites met conventional mapping criteria for ablation,^{13 14} temperature-controlled radiofrequency energy (RF) was delivered. These sites were then identified by off-line analysis, for which successful ablation was defined as RF terminating VT and partial success as RF changing VT morphology, after both of which the original VT was noninducible.

View larger version (47K): [in this window] [in a new window]   Figure 1. Detail from screen of noncontact system workstation. MEA position is represented as a yellow frame within "virtual" endocardium. Virtual endocardium is opened and unfolded along inferior septum so that edges are in continuity. Anatomic locations identified on fluoroscopy were marked on map with yellow labels by use of catheter locator system. Inf indicates inferior; Post lat, posterolateral; Ant lat, anterolateral; Ant, anterior; and sept, septal. Reconstructed isopotential map is superimposed onto virtual LV. Color scale shown below virtual endocardium is set so that white represents endocardial regions <-1.5 mV and purple represents >-1.49 mV (thus producing an activation map). Green locator line emerging from MEA marks position of a mapping catheter electrode in LV. Map shows activation at VT exit as white dot. Below map is a waveform window showing reconstructed electrograms from exit (B and C), surface ECG, and mapping catheter electrogram sited remote from exit. White line on waveform window represents position in time represented by map.

View larger version (83K): [in this window] [in a new window]   Figure 2. Frames of sequential unipolar isopotential maps from same patient as Figure 1. Activation is shown as white/colored areas on purple background of map. Site of successful RF is shown by green dot. Frame 1 shows VT exit. Frames 2 and 3 show systolic activation. Frame 4 shows activation entering DP. Frames 5 through 8 show activation progressing along DP to VT exit. Identification of DP is performed in reverse of order of frames shown here, so that exit is first identified (frame 1) and DP is then identified by moving isopotential map back in time through frame 8 back to 4 or until continuity of diastolic activity is interrupted.

Statistics
Continuous data are presented as mean and SD and analyzed by Student's t test. Data of the relation between catheter location and the outcome of RF was analyzed with ² analysis.

	Results

Top Abstract Introduction Methods Results Discussion References

 
Data were collected from all patients during VT (Table 2). Ablation was completed in 22 patients and was not performed because ventricular fibrillation (VF) was followed by cardiogenic shock in 1 patient and because of facial weakness after transseptal puncture before multielectrode array (MEA) introduction in another.

View this table: [in this window] [in a new window]   Table 2. Procedural Data

Validation of Reconstructed Electrograms During VT
Cross-correlation analyzed 7593 (range, 40 to 1731) unipolar VT electrograms. Cross-correlation of contact and reconstructed electrograms was 0.86±0.16 (mean±SD) (Figure 3). The timing shift that produced the closest electrogram match was -1.67±10.46 ms.

View larger version (20K): [in this window] [in a new window]   Figure 3. Histogram showing cross-correlation between contact and reconstructed electrograms recorded during VT. Majority of compared electrograms had a perfect correlation (1), and almost all comparisons gave a correlation >0.8, which was considered to be an acceptable value.

Mapping
Eighty-one of 97 VTs were mapped with the MEA (3.4 per patient). Sixteen VTs were recorded only before MEA introduction. Twenty-four mapped VTs were clinical. Noncontact mapping identified 80 (99%) of 81 VT exits and diastolic activity connecting to this in 54 (67%). In 17 VTs, complete reentrant circuits were mapped (Figure 4A and 4B). Of these, 7 were successfully ablated, all from within mapped diastolic pathways (DPs). The other 10 were not ablated either because of hemodynamic instability (n=2) or because the VT was induced only once (n=8). In the remaining 37 VTs, diastolic activity was traced over 36±30% (range, 1% to 95%) of the diastolic interval.

View larger version (108K): [in this window] [in a new window]   Figure 4. A, Maps of VT. Virtual endocardium has been opened along anterior septum. Anatomic labels are as follows: Base and Apex, LV base and apex; Septum, LV septum; Lateral, LV lateral wall. Successful RF site is shown with green dot. Direction of activation is shown with blue arrows. Letters A through E represent positions at which electrograms have been reconstructed and displayed in Figure 4B. Frames 1 and 2 show end of systole. Diastolic activity progresses from base to apex in frames 3 and 4 before wave front splits in frame 5. Anteroseptal wave front moves from base to apex (frame 6) before blocking (bystander) (frame 7). A more posterior wave front goes from base to apex (frames 5 and 6), turns at apical end (frame 6), and progresses basally (frames 7 and 8). Wave front exits DP, resulting in systolic activation (frames 9, 10, 1, 2). B, Waveform window shows reconstructed bipolar electrograms from sites A through E in panel A with different bipole directions, enhancing diastolic potentials, which progress in time from E to A before LV systolic activation. Also shown is a bipolar electrogram from a contact catheter located at RF site in Figure 4A and ECG lead V3. Contact electrogram is timed between electrograms B and A and is saturated because pacing has been used to prove concealed entrainment.

Ablation
One hundred fifty-four RF applications (range, 0 to 34 per patient) ablated a total of 38 (15 clinical) VTs (4 RFs per VT). Four VTs were ablated by 2 RF applications on shared DPs (Figures 5 and 6). Seventy-six RFs were delivered during VT, with 22 successful, 9 partially successful, and 45 unsuccessful. Of RFs applied to a mapped DP, 77% successfully ablated VT. RF delivered to exit sites was significantly less successful (P<0.005) and failed to eliminate VT in 79%, either changing morphology or causing no change to the VT. RF delivered remote from the VT DP was significantly less successful (P<0.0001), failing in 91% of applications. RF applied close to incompletely identified DPs succeeded in 80% of cases (Table 3).

View larger version (87K): [in this window] [in a new window]   Figure 5. A, VT1 electrograms showing contact electrograms recorded at successful RF site in Figure 6 with late diastolic potentials (dp). Diastolic potentials on distal bipole lead proximal bipole. B, VT4 electrograms. Mapping catheter is positioned at same site as in Figures 5A and 6 and shows early diastolic potentials. Timing of diastolic potentials on distal and proximal bipoles is now reversed. C, Electrograms during pacing from VT4 DP from same site as in Figures 5A and 5B and 6, resulting in acceleration of VT4. An increasing stimulus to QRS interval results from rapid pacing, leading to VT4 termination. After 2 cycles, a perfect pace match of VT1 is seen, suggesting reversal of diastolic activation with a shorter pacing to QRS interval. Pacing is closely followed by spontaneous onset of VT1, which confirms accuracy of pace match.

View this table: [in this window] [in a new window]   Table 3. Results of RF Application During VT

Complications
No cardiac complications resulted from MEA use. The first 2 patients developed false femoral artery aneurysms requiring surgical repair, 1 at the site of MEA introduction. Subsequently, anticoagulation was reversed, and sheaths were removed immediately with no further vascular complication. Other procedural complications were cerebrovascular event (n=1) before MEA deployment, cardiogenic shock after VF (n=1), and hemothorax (n=1) after transseptal puncture. A patient with incessant VT and hypotension died 12 hours after the procedure of cardiogenic shock exacerbated by cardiac tamponade from a 100-mL effusion through a right ventricular perforation by a preexisting temporary catheter.

Follow-Up
Of 22 patients ablated, 14 (64%) have had no VT over a mean follow-up of 1.5 years (range, 0.6 to 2.5 years). Of 38 target VTs, 2 (5.3%) recurred; both were then successfully ablated. In 2 patients, slower nonsustained target VT recurred at 1 week and 1 year. In 1 patient, documented fast VT recurred after 6 months. Two patients had new VTs >3 months after the procedure.

Four patients have died, 1 of myocardial infarction 3 days after the procedure. A patient with an ICD and dilated cardiomyopathy died 3 months later of incessant VF, with no recurrence of VT before this. Two patients were free of VT but died 6 and 18 months, respectively, after the procedure, 1 of noncardiac and 1 of unknown causes.

For those patients with preexisting ICDs, over a follow-up of 1.19±0.7 years, shock frequency was reduced from 9.2 per year (range, 2 to 23) to 0.16 (P<0.05).

In 7 patients, ICDs were implanted after ablation because of rapid VT during the procedure. No therapy has been delivered by these ICDs. None of the remaining 9 patients have had recurrence of VT. Antiarrhythmics were stopped in the 2 patients with normal hearts and unchanged in the 7 with structural heart disease.

	Discussion

Top Abstract Introduction Methods Results Discussion References

 
We report the first use of noncontact mapping of human VT, which identified exit sites in 99% and diastolic portions of VT reentry circuits in 67%. Thirty-eight VTs were ablated, with a >78% success rate over a follow-up period of 1 year in patients who survived the perioperative period.

The most common cause for clinical VT is coronary heart disease.^{15 16} Catheter ablation of such VTs has been limited, by the time required for sequential endocardial activation mapping,¹² to those with hemodynamically stable VT. The results have been disappointing, with immediate success rates of 71% to 90%,^{13 17 18} but recurrence is common.

Simultaneous epicardial and endocardial activation mapping has been performed at surgery with multiple electrodes on the epicardium or on a balloon introduced transmitrally to the endocardium.¹⁹ These circumstances may modify the substrate,¹⁴ with associated morbidity and mortality.²⁰ Percutaneous endocardial basket arrays simultaneously map multiple endocardial points. Resolution is limited to those electrodes in endocardial contact and by unequal deployment of the splines.²¹

Noncontact mapping, as described, allows high-resolution simultaneous activation maps of the entire cardiac chamber from just 1 beat of VT. Noncontact endocardial mapping was first described by Taccardi et al²² in 1987, when olive and cylindrical probes recorded canine ventricular paced electrograms, producing potentials of low frequency and amplitude.²³ To enhance these, principles previously used to reconstruct epicardial maps from skin surface electrograms²⁴ were applied.^{25 26} Noncontact mapping using cylindrical probes in open-chest dogs with an epicardial echocardiographic geometry matrix demonstrated good correlation between contact and reconstructed electrograms.²⁶

The system described here uses a percutaneous catheter-mounted electrode array. It combines inverse-solution mathematics with a catheter location device, creating several advantages over previous systems. First, a representation of cavity geometry is obtained, and second, the progress of a catheter within the cavity can be continuously monitored during mapping.^{11 27}

Despite several theoretical situations in which contact and the corresponding reconstructed electrogram may differ, good correlation between contact and reconstructed electrograms from the same sites have been shown, with accuracy decreasing with increasing endocardium-MEA distance, especially when this distance is >34 mm.¹¹ Further validation, by cross-correlation comparison of reconstructed and contact electrograms recorded from the same site during VT, is presented in this article, showing a good correlation of 0.86±0.16 and a mean timing error of -1.67±10.06 ms.

The exit site was identified in 99% of VTs. In 67%, the MEA also identified a DP leading to the exit site. This was used as an initial target for confirmation by conventional mapping. Sites found suitable for ablation were validated by comparing the locations of successful and unsuccessful ablation sites with those of the DP on the map. RF delivered on a mapped DP was significantly more successful than RF delivered on an exit or remote from the DP. The success rates for RF near incompletely identified DPs may reflect the small numbers and the fact that the ablation catheter had been positioned where diastolic activity had been identified by the MEA but did not qualify as relevant DP under our strict definition. Failure of RF applied to DPs may be due to catheter movement, inadequate lesion size, or errors in positioning the catheter or identifying the DP. However, these data suggest that mapped DPs are clinically relevant and are the optimum location for ablation of VT, with a 93% (12/13) success or partial success rate. RF applications to mapped exit sites were partially or completely successful in 50% but more often changed morphology than terminated VT. Of the VT DPs identified entirely and ablated successfully, RF was within or immediately adjacent to the mapped DP in all cases.

There are several possibilities why the MEA failed to identify a complete VT circuit. Perhaps some of the DP electrograms were too small to be detected or were intramural or epicardial^{6 28 29} and therefore could not be detected by the MEA. In some, the DPs were far from the MEA. Previous validation data indicate that this may affect the accuracy of electrogram reconstruction.¹¹ However, the locations of parts of some DPs identified completely were >40 mm from the MEA and thus beyond the theoretical distance for optimal reconstruction. It is therefore difficult to be certain of the importance of distance in electrogram reconstruction. Once the current design of the MEA is deployed, it remains stable, so that the initial acquisition of chamber geometry remains valid for the procedure.

A difficulty with identifying diastolic components of some VT reentry circuits is saturation of the maps by LV repolarization. Although high-pass filtering will reduce this, it also attenuates diastolic electrograms and thus may not distinguish between the two. We have attempted to avoid this by our strict definition of relevant diastolic activity, but significant portions of the DP may be hidden by repolarization.

The long-term follow-up in 20 patients who survive indicates that 14 had no VT recurrence and a further 3 had recurrence of new VT morphologies. The recurrence of target VT was low, at 5.4% (2 of 37 VTs), even though 43 VTs induced during the procedures were either not targeted or not ablated successfully. It is possible that they were either clinically irrelevant or dependent on the same substrate as the ablated VTs. Maps have demonstrated different VTs sharing portions of the same DP either in contrarotation or with different exits. Also, where complete DPs could not be identified, it was apparent that the exit sites of several VTs were close, so that they may have shared DPs. Many VTs became difficult to induce or sustain during a study. In this situation, the DP was located by use of VT maps recorded earlier. This area was then conventionally mapped during sinus rhythm when RF was applied, which may have resulted in ablation of VT.

Limitations of the Study
Because this study describes initial experience and development of a novel technology, it is largely descriptive and has a limited number of patients. Our validation by comparing the DPs identified by the system with the location of successful RF sites is not controlled and is subject to observer bias. The limited resolution of conventional percutaneous endocardial mapping and catheter location techniques prevents creation of comparable contact isopotential maps.

In addition, identification of DPs relied on the assumption that all VT exits were endocardial, but some may have been epicardial with endocardial breakthrough identified. Comparison of the locations of successful and unsuccessful RF sites relative to DPs partly addresses this.

Conclusions
Noncontact mapping safely mapped and guided ablation of VT in human LVs. It rapidly identified VT exit sites and thus starting points for conventional mapping. In >50% of cases, it identified some of the DPs and therefore suitable targets for ablation, allowed monitoring of the position of other catheters, and demonstrated a relationship between the site of the DP and the outcome of RF application.

View larger version (104K): [in this window] [in a new window]   Figure 6. Maps recorded during VTs shown in Figure 5, with 2 VTs using same DP in contrarotation. Virtual endocardium has been opened along anterior septum so that 2 edges are in continuity. Anatomic locations as in previous figures. Activation is shown by white areas. Successful RF site is shown with a green dot. A, VT1. Frame 1 shows DP activation just before exit. Frames 2 through 4 show LV systolic activation. Frames 5 through 8 show activation progressing along DP from apical septum to a basolateral exit. B, VT4. Frames 1 through 4 show activation in DP progressing from basal and lateral (exit site for VT shown in Figure 6A) toward an exit in apical septum. Frames 5 through 7 show LV systolic activation of LV.

Received June 3, 1998; revision received February 18, 1999; accepted February 23, 1999.

	References

Top Abstract Introduction Methods Results Discussion References

 
1. Roberts SA, Viana MA, Nazari J, Bauman JL. Invasive and noninvasive methods to predict the long term efficacy of amiodarone. Pacing Clin Electrophysiol. 1994;17:1590–1602.[Medline] [Order article via Infotrieve]

2. Roy D, Waxman HL, Kienzle MG, Buxton AE, Marchlinski FE, Josephson ME. Clinical characteristics and long term follow-up in 119 survivors of cardiac arrest: relation to inducibility at electrophysiological testing. Am J Cardiol. 1983;52:969–974.[Medline] [Order article via Infotrieve]

3. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med. 1989;321:406–412.[Abstract]

4. Greene HL. Antiarrhythmic drugs versus implantable defibrillators: the need for a randomized controlled study. Am Heart J. 1994;127:1171–1178.[Medline] [Order article via Infotrieve]

5. Bocker D, Breithardt G, Block M, Borggrefe M. Management of patients with ventricular tachyarrhythmias: does an optimal therapy exist? Pacing Clin Electrophysiol. 1994;17:559–570.[Medline] [Order article via Infotrieve]

6. Josephson ME, Horowitz LN, Farshidi A, Kastor JA. Recurrent sustained ventricular tachycardia, I: mechanisms. Circulation. 1978;57:431–439.[Abstract/Free Full Text]

7. Stevenson WG, Khan H, Sager P, Saxon LA, Middlekauff HR, Natterson PD, Wiener I. Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction. Circulation. 1993;88:1647–1670.[Abstract/Free Full Text]

8. El-Sherif N, Mehra R, Gough WB, Zeiler RH. Reentrant ventricular arrhythmias in the late myocardial infarction period: interruption of reentrant circuits by cryothermal techniques. Circulation. 1983;68:644–656.[Abstract/Free Full Text]

9. Morady F, Harvey M, Kalbfleisch SJ, El-Atassi R, Calkins H, Lanberg JJ. Radiofrequency ablation of ventricular tachycardia in patients with coronary artery disease. Circulation. 1993;87:363–372.[Abstract/Free Full Text]

10. Peters NS, Jackman W, Schilling RJ, Beatty G, Davies DW. Human left ventricular endocardial activation mapping using a novel non-contact catheter. Circulation. 1997;95:1658–1660.[Free Full Text]

11. Schilling RJ, Peters NS, Davies DW. A non-contact catheter for simultaneous endocardial mapping in the human left ventricle: comparison of contact and reconstructed electrograms during sinus rhythm. Circulation. 1998;98:887–898.[Abstract/Free Full Text]

12. Gepstein L, Hayam G, Ben-Haim S. A novel method for nonfluoroscopic catheter-based electroanatomical mapping of the heart. Circulation. 1997;95:1611–1622.[Abstract/Free Full Text]

13. Morady F, Kadish A, Rosenheck S, Calkins H, Kou WH, De Buitleir M, Sousa J. Concealed entrainment as a guide for catheter ablation of ventricular tachycardia in patients with prior myocardial infarction. J Am Coll Cardiol. 1991;17:678–689.[Abstract]

14. Josephson ME, Horowitz LN, Spielman SR, Waxman HL, Greenspan AM. Role of catheter mapping in the preoperative evaluation of ventricular tachycardia. Am J Cardiol. 1982;49:207–221.[Medline] [Order article via Infotrieve]

15. de Bakker JMT, van Capelle FJL, Janse MJ, Wilde AA, Coronel R, Becker AE, Dingemans KP, van Hemel NM, Hauer RN. Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. Circulation. 1988;77:589–606.[Abstract/Free Full Text]

16. Ursell PC, Gardner PI, Albala A, Fenoglio JJ Jr, Wit AL. Structural and electrophysiological changes in the epicardial border zone of canine myocardial infarcts during infarct healing. Circ Res. 1985;56:436–451.[Abstract/Free Full Text]

17. Rothman SA, Hsia HH, Cossu SF, Chmielewski IL, Buxton AE, Miller JM. Radiofrequency catheter ablation of post-infarction ventricular tachycardia: long-term success and the significance of inducible non-clinical arrhythmias. Circulation. 1997;97:3499–3508.

18. Borggrefe M, Chen X, Hindricks G, Haverkamp W, Willems S, Martinez-Rubio A, Shenasa M, Rotman B, Breithardt G. Catheter ablation of ventricular tachycardia in patients with heart disease. In Zipes DP, ed. Catheter Ablation of Arrhythmias. Armonk, NY: Futura Publishing Co, Inc; 1994:277–308.

19. Downar E, Saito J, Doig JC, Chen TC, Sevaptsidis E, Masse S, Kimber S, Mickleborough L, Harris L. Endocardial mapping of ventricular tachycardia in the intact human ventricle, III: evidence of multiuse reentry with spontaneous and induced block in portions of reentrant path complex. J Am Coll Cardiol. 1995;25:1591–1600.[Abstract]

20. Mickleborough LL, Mizuno S, Downar E, Gray GC. Late results of operation for ventricular tachycardia. Ann Thorac Surg. 1992;54:832–838.[Abstract]

21. Johnson SB, Packer DL. Intracardiac ultrasound guidance of multipolar atrial and ventricular mapping basket applications. J Am Coll Cardiol. 1997;29:202A. Abstract.

22. Taccardi B, Arisi G, Macchi E, Baruffi S, Spaggiari S. A new intracavitary probe for detecting the site of origin of ectopic ventricular beats during one cardiac cycle. Circulation. 1987;75:272–281.[Abstract/Free Full Text]

23. Khoury DS, Rudy Y. A model study of volume conductor effects on endocardial and intracavitary potentials. Circ Res. 1992;71:511–525.[Abstract/Free Full Text]

24. Rudy Y, Messinger-Rapport BJ. The inverse problem in electrocardiography: solutions in terms of epicardial potentials. Crit Rev Biomed Eng. 1988;16:214–268.

25. Macchi E, Arisi G, Colli-Franzone P, Guerri L, Olivetti G, Taccardi B. Localization of ventricular ectopic beats from intracavitary potential distributions: an inverse model in terms of sources. Proc 11^th IEEE/EMBS. 1989:191–192.

26. Khoury DS, Taccardi B, Lux RL, Ershler PR, Rudy Y. Reconstruction of endocardial potentials and activation sequences from intracavity probe measurements: localization of pacing sites and effects of myocardial structure. Circulation. 1995;91:845–863.[Abstract/Free Full Text]

27. Beatty GE, Remole SC, Hansen R, Johnston MK, Holte JE, Benditt DG. Non-contact electrical extrapolation technique to reconstruct endocardial potentials. Pacing Clin Electrophysiol. 1994;17:765. Abstract.

28. Svenson RH, Littmann L, Gallagher JJ, Selle JG, Zimmern SH, Fedor JM, Colavita PG. Termination of ventricular tachycardia with epicardial laser photocoagulation: a clinical comparison with patients undergoing successful endocardial photocoagulation alone. J Am Coll Cardiol. 1990;15:163–170.[Abstract]

29. Littmann L, Svenson RH, Gallagher JJ, Selle JG, Zimmern SH, Fedor JM, Colavita PG. Functional role of the epicardium in postinfarction ventricular tachycardia: observations derived from computerized epicardial activation mapping, entrainment, and epicardial laser photoablation. Circulation. 1991;83:1577–91.[Abstract/Free Full Text]

This article has been cited by other articles:

				E. M. Aliot, W. G. Stevenson, J. M. Almendral-Garrote, F. Bogun, C. H. Calkins, E. Delacretaz, P. D. Bella, G. Hindricks, P. Jais, M. E. Josephson, et al. EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: Developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA) Europace, June 1, 2009; 11(6): 771 - 817. [Full Text] [PDF]

				G. Sivagangabalan, J. Pouliopoulos, K. Huang, J. Lu, M. A. Barry, A. Thiagalingam, D. L. Ross, S. P. Thomas, and P. Kovoor Comparison of Electroanatomic Contact and Noncontact Mapping of Ventricular Scar in a Postinfarct Ovine Model With Intramural Needle Electrode Recording and Histological Validation Circ Arrhythmia Electrophysiol, December 1, 2008; 1(5): 363 - 369. [Abstract] [Full Text] [PDF]

				T. Yamada, Y. Murakami, T. Okada, H. T. McElderry, H. Doppalapudi, A. E. Epstein, V. J. Plumb, T. Murohara, and G. N. Kay Electroanatomic mapping in the catheter ablation of premature atrial contractions with a non-pulmonary vein origin Europace, November 1, 2008; 10(11): 1320 - 1324. [Abstract] [Full Text] [PDF]

				C. Knackstedt, P. Schauerte, and P. Kirchhof Electro-anatomic mapping systems in arrhythmias Europace, November 1, 2008; 10(suppl_3): iii28 - iii34. [Abstract] [Full Text] [PDF]

				C. Carbucicchio, M. Santamaria, N. Trevisi, G. Maccabelli, F. Giraldi, G. Fassini, S. Riva, M. Moltrasio, M. Cireddu, F. Veglia, et al. Catheter Ablation for the Treatment of Electrical Storm in Patients With Implantable Cardioverter-Defibrillators: Short- and Long-Term Outcomes in a Prospective Single-Center Study Circulation, January 29, 2008; 117(4): 462 - 469. [Abstract] [Full Text] [PDF]

				M. W. Kimmel, N. D. Skadsberg, C. L. Byrd, D. J. Wright, T. G. Laske, and P. A. Iaizzo Single-site ventricular and biventricular pacing: investigation of latest depolarization strategy Europace, December 1, 2007; 9(12): 1163 - 1170. [Abstract] [Full Text] [PDF]

				T. Kriebel, J. P. Saul, H. Schneider, M. Sigler, and T. Paul Noncontact Mapping and Radiofrequency Catheter Ablation of Fast and Hemodynamically Unstable Ventricular Tachycardia After Surgical Repair of Tetralogy of Fallot J. Am. Coll. Cardiol., November 27, 2007; 50(22): 2162 - 2168. [Abstract] [Full Text] [PDF]

				H. U. Klemm, R. Ventura, D. Steven, C. Johnsen, T. Rostock, B. Lutomsky, T. Risius, T. Meinertz, and S. Willems Catheter Ablation of Multiple Ventricular Tachycardias After Myocardial Infarction Guided by Combined Contact and Noncontact Mapping Circulation, May 29, 2007; 115(21): 2697 - 2704. [Abstract] [Full Text] [PDF]

				O. R. Segal, A. W.C. Chow, V. Markides, D. W. Davies, and N. S. Peters Characterization of the Effects of Single Ventricular Extrastimuli on Endocardial Activation in Human Infarct-Related Ventricular Tachycardia J. Am. Coll. Cardiol., March 27, 2007; 49(12): 1315 - 1323. [Abstract] [Full Text] [PDF]

				M. J. Earley, D. J.R. Abrams, S. C. Sporton, and R. J. Schilling Validation of the Noncontact Mapping System in the Left Atrium During Permanent Atrial Fibrillation and Sinus Rhythm J. Am. Coll. Cardiol., August 1, 2006; 48(3): 485 - 491. [Abstract] [Full Text] [PDF]

				M C S Hall and D M Todd Modern management of arrhythmias Postgrad. Med. J., February 1, 2006; 82(964): 117 - 125. [Abstract] [Full Text] [PDF]

				J. Triedman Virtual Reality in Interventional Electrophysiology Circulation, December 13, 2005; 112(24): 3677 - 3679. [Full Text] [PDF]

				T. H. Everett IV, E. E. Wilson, S. Foreman, and J. E. Olgin Mechanisms of Ventricular Fibrillation in Canine Models of Congestive Heart Failure and Ischemia Assessed by In Vivo Noncontact Mapping Circulation, September 13, 2005; 112(11): 1532 - 1541. [Abstract] [Full Text] [PDF]

				H. U. Klein and S. Reek "The Older the Broader": Electrogram Characteristics Help Identify the Critical Isthmus During Catheter Ablation of Postinfarct Ventricular Tachycardia J. Am. Coll. Cardiol., August 16, 2005; 46(4): 675 - 677. [Full Text] [PDF]

				P. Della Bella, S. Riva, G. Fassini, F. Giraldi, M. Berti, C. Klersy, and N. Trevisi Incidence and significance of pleomorphism in patients with postmyocardial infarction ventricular tachycardia: Acute and long-term outcome of radiofrequency catheter ablation Eur. Heart J., July 1, 2004; 25(13): 1127 - 1138. [Abstract] [Full Text] [PDF]

				G. C Kaye Percutaneous interventional electrophysiology BMJ, July 31, 2003; 327(7409): 280 - 283. [Full Text] [PDF]

				E. J. Ciaccio Premature excitation and onset of reentrant ventricular tachycardia Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1703 - H1712. [Abstract] [Full Text] [PDF]

				P. A. Friedman, S. J. Asirvatham, S. Grice, M. Glikson, T. M. Munger, R. F. Rea, W. K. Shen, A. Jahanghir, D. L. Packer, and S. C. Hammill Noncontact mapping to guide ablation of right ventricular outflow tract tachycardia J. Am. Coll. Cardiol., June 5, 2002; 39(11): 1808 - 1812. [Abstract] [Full Text] [PDF]

				P. A Friedman Novel mapping techniques for cardiac electrophysiology Heart, June 1, 2002; 87(6): 575 - 582. [Full Text] [PDF]

				H. Kottkamp and G. Hindricks Catheter ablation of untolerated ventricular tachycardia--a new front line Eur. Heart J., May 1, 2002; 23(9): 697 - 699. [Full Text] [PDF]

				P. Della Bella, A. Pappalardo, S. Riva, C. Tondo, G. Fassini, and N. Trevisi Non-contact mapping to guide catheter ablation of untolerated ventricular tachycardia Eur. Heart J., May 1, 2002; 23(9): 742 - 752. [Abstract] [Full Text] [PDF]

				R.J. Schilling Can catheter ablation cure post-infarction ventricular tachycardia? Eur. Heart J., March 1, 2002; 23(5): 352 - 354. [Full Text] [PDF]

				R. J. Schilling, N. S. Peters, J. Goldberger, A. H. Kadish, and D. W. Davies Characterization of the anatomy and conduction velocities of the human right atrial flutter circuit determined by noncontact mapping J. Am. Coll. Cardiol., August 1, 2001; 38(2): 385 - 393. [Abstract] [Full Text] [PDF]

				G. Hindricks and H. Kottkamp Simultaneous Noncontact Mapping of Left Atrium in Patients With Paroxysmal Atrial Fibrillation Circulation, July 17, 2001; 104(3): 297 - 303. [Abstract] [Full Text] [PDF]

				T. Paul, B. Windhagen-Mahnert, T. Kriebel, H. Bertram, R. Kaulitz, T. Korte, M. Niehaus, and J. Tebbenjohanns Atrial Reentrant Tachycardia After Surgery for Congenital Heart Disease : Endocardial Mapping and Radiofrequency Catheter Ablation Using a Novel, Noncontact Mapping System Circulation, May 8, 2001; 103(18): 2266 - 2271. [Abstract] [Full Text] [PDF]

				D W. DAVIES Catheter ablation of ventricular tachycardia: are there limits? Heart, December 1, 2000; 84(6): 585 - 586. [Full Text]

				W. G Stevenson and E. Delacretaz ELECTROPHYSIOLOGY: Radiofrequency catheter ablation of ventricular tachycardia Heart, November 1, 2000; 84(5): 553 - 559. [Full Text]

				G. L. Pierpont, S. S. Chugh, J. A. Hauck, and C. C. Gornick Endocardial activation during ventricular fibrillation in normal and failing canine hearts Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1737 - H1747. [Abstract] [Full Text] [PDF]

				R.J. Schilling, D.W. Davies, and N.S. Peters Clinical developments in cardiac activation mapping Eur. Heart J., May 2, 2000; 21(10): 801 - 807. [PDF]

				R.J Schilling, A.H Kadish, N.S Peters, J Goldberger, and D.W. Davies Endocardial mapping of atrial fibrillation in the human right atrium using a non-contact catheter Eur. Heart J., April 1, 2000; 21(7): 550 - 564. [Abstract] [PDF]

				S. A. Strickberger, B. P. Knight, G. F. Michaud, F. Pelosi, and F. Morady Mapping and ablation of ventricular tachycardia guided by virtual electrograms using a noncontact, computerized mapping system J. Am. Coll. Cardiol., February 1, 2000; 35(2): 414 - 421. [Abstract] [Full Text] [PDF]

				A. W.C. Chow, R. J. Schilling, D. W. Davies, and N. S. Peters Characteristics of Wavefront Propagation in Reentrant Circuits Causing Human Ventricular Tachycardia Circulation, May 7, 2002; 105(18): 2172 - 2178. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schilling, R. J. Articles by Davies, D. W. Search for Related Content PubMed PubMed Citation Articles by Schilling, R. J. Articles by Davies, D. W. Related Collections Electrophysiology Catheter-based coronary interventions: stents Arrhythmias, clinical electrophysiology, drugs